Drug checking can reveal important information about research chemical samples, but no test can guarantee safety. This European guide explains what analytical testing detects, why results can be incomplete, and how toxicology supports risk awareness.
NPS monitoring in Europe combines laboratory analysis, hospital reports, poison-centre data, wastewater testing, and early-warning networks to identify emerging psychoactive substances before risks become widespread.
Identification is the foundation of every responsible research chemical practice. This guide explains how compounds are verified in European laboratories in 2026, what drug-checking services can and cannot detect, and why analytical confirmation matters more than ever as novel psychoactive substances proliferate.
European rules on novel psychoactive substances are shifting again in 2025. This guide explains how EU research chemical regulations work, how the EU-wide ban process operates, why national transposition matters, and what laboratories and researchers should understand about NPS legislation across Europe.